The TGA Advertising hub still notes:
“We are experiencing intermittent IT issues that are impacting this form. If you experience an error lodging a complaint, please try again later. We are working to fix this issue as a matter of priority”.
Regardless, I’ve now been able to submit six complaints that I’ve suggested are high priority.
They are all based on previous complaints upheld by the CRP but whose sponsor (and others) continue to make claims that were determined to breach the Therapeutic Goods Advertising Code.
- Complaint to TGA: Pharmacare Laboratories Ease-a-cold products, 5 July 2018, AL-B81GN1V3/2018
- Complaint to TGA: Pharmacare Laboratories Promensil Menopause products, 6 July 2018, AC-4I7BPN1V/2018.
- Complaint to TGA: Pharmacare Laboratories FatBlaster FatMagnet products, 6 July 2018, AC-GBKDH2XG/2018
- Complaint to TGA: Pharmacare Laboratories Nature’s Way Magnesium Products, 7 July 2018, AC-GOZU449N/2018
- Complaint to TGA: Pharmacare Laboratories Sambucol Products, 9 July 2018, AC-FR55H9ST/2018
- Complaint to TGA: Weleda Arnica Homeopathic Products, 10 July 2018, AC-I9WC23OP/2018got
There are now a few complaint “outcomes” appearing on the TGA web site . All have assessed by the TGA as “low priority” and the outcome” is merely a ‘Compliance notice sent with educational material”.
There are no details of the complaint, product or sponsor that would enable one to check the priority assigned, let alone see if the “notice” actually achieved compliance! As predicted, very convenient for the sponsor and the TGA .by